repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
specif
antibodi
antiflag
shown
quantif
amount
europium
releas
bound
liposom
addit
delfia
enhanc
solut
contain
deterg
onestep
purif
protein
appear
effici
incorpor
two
protein
liposom
seem
quantit
pellet
ultracentrifug
contain
fluoresc
label
rv
protein
coexpress
two
protein
insect
cell
enabl
format
heterodimer
complex
would
broaden
use
type
rvspecif
virosom
entrap
lanthanid
chelat
label
addit
potenti
use
kind
particl
diagnost
strategi
may
also
enabl
studi
aim
solv
problem
relat
basic
biolog
known
viral
membran
fusion
protein
type
integr
membran
protein
contain
fusion
peptid
within
ectodomain
special
featur
viral
fusion
protein
resid
virion
surfac
metast
entiti
three
viral
fusion
protein
whose
metast
structur
probe
highresolut
xray
crystallographi
electron
microscopyth
influenza
hemagglutinin
ha
e
glycoprotein
tickborn
enceph
viru
tbe
glycoprotein
semliki
forest
viru
sfv
fusion
peptid
buri
within
ectodomain
protein
consequ
ectodomain
protein
fulli
water
solubl
releas
transmembran
domain
viral
fusion
protein
divid
two
class
influenza
ha
prototyp
class
viral
fusion
protein
employ
coiledcoil
motif
fusion
tbe
e
sfv
glycoprotein
class
ii
viral
fusion
protein
employ
altern
motif
fusion
nonetheless
three
glycoprotein
undergo
dramat
conform
chang
low
ph
condit
virus
encount
cellular
endosom
receptormedi
endocytosi
tabl
although
specif
conform
chang
differ
class
class
ii
viral
fusion
protein
major
consequ
low
phinduc
conform
chang
formerli
watersolubl
protein
ectodomain
bind
tenaci
hydrophob
target
membran
three
case
hydrophob
bind
target
membran
shown
occur
fusion
peptid
low
phinduc
hydrophob
bind
glycoprotein
target
bilay
oblig
prerequisit
membran
fusion
henc
key
common
step
among
viral
fusion
glycoprotein
convers
ectodomain
hydrophil
hydrophob
entiti
virtu
expos
fusion
peptid
fig
step
although
mani
envelop
virus
includ
seriou
pathogen
influenza
viru
ebola
viru
west
nile
viru
activ
fusion
exposur
low
ph
mani
other
includ
seriou
pathogen
human
immunodefici
viru
hiv
herpesvirus
respiratori
syncyti
viru
rsv
fuse
cell
neutral
ph
current
concept
instead
activ
low
ph
virus
activ
specif
interact
viral
glycoprotein
cognat
host
cell
receptor
tabl
concept
first
emerg
studi
propos
twostep
entri
mechan
requir
receptor
bind
neutral
ph
follow
exposur
low
ph
retrovirus
except
mmtv
shown
fuse
neutral
ph
viral
fusion
protein
bind
target
membran
simpl
model
alpharetroviru
avian
sarcomaleukosi
viru
aslv
formerli
known
rou
sarcoma
viru
receptor
viru
small
solubl
type
integr
membran
glycoprotein
call
tva
acronym
denot
receptor
avian
tumor
viru
subtyp
shown
bind
glycoprotein
small
acid
solubl
form
tva
ectodomain
stva
could
induc
solubl
trimer
form
aslv
subtyp
aslva
envelop
glycoprotein
ectodomain
envapi
bind
hydrophob
target
membran
neutral
ph
bind
target
membran
occur
depend
wildtyp
fusion
peptid
sequenc
similar
result
obtain
subsequ
anoth
laboratori
yet
like
rel
simplic
avian
retroviru
system
one
viral
glycoprotein
one
simpl
host
cell
receptor
tabl
aslv
enva
viral
glycoprotein
proven
enva
undergo
conform
chang
fusion
peptid
expos
penetr
target
membran
penetr
target
membran
fusion
peptid
step
trimer
may
cluster
step
conform
chang
occur
enva
begin
step
form
form
step
sixhelix
bundl
mediat
lipid
mix
outer
leaflet
target
viral
membran
action
fusion
peptid
transmembran
domain
hemifus
diaphragm
would
open
fusion
pore
step
model
base
similar
model
influenza
ha
case
ha
trigger
step
exposur
low
ph
liposom
molecular
cell
biolog
bind
target
membran
temperaturedepend
interact
host
cell
receptor
work
suggest
aslv
env
fulli
activ
fusion
receptor
bind
neutral
ph
rather
requir
receptor
bind
neutral
ph
elev
temperatur
follow
exposur
low
ph
found
howev
neither
hydrophob
bind
subtyp
envelop
glycoprotein
target
membran
bind
aslva
viru
particl
target
membran
lipid
mix
viral
aslva
cellular
membran
requir
exposur
low
ph
therefor
critic
step
activ
aslva
viral
fusion
protein
occur
neutral
ph
remain
section
chapter
describ
three
assay
develop
monitor
receptorinduc
associ
aslv
enva
target
bilay
origin
assay
monitor
bind
enva
ectodomain
envapi
target
membran
liposom
modifi
miniatur
envapiliposom
bind
assay
assay
measur
bind
intact
aslva
viru
particl
target
membran
envapi
envapi
prepar
describ
previous
viral
fusion
protein
bind
target
membran
mgml
leupeptin
mgml
aprotinin
mgml
antipain
mgml
benzamidin
mgml
soybean
trypsin
inhibitor
sti
mg
ml
iodoactamid
mgml
viru
aslva
produc
cell
chronic
infect
rcasbp
gfp
tube
place
ice
sampl
brought
final
concentr
sucros
ad
l
sucros
step
gradient
layer
top
sampl
addit
l
sucros
l
sucros
sucros
solut
made
weight
per
weight
pb
without
ca
mg
sampl
centrifug
g
h
rotor
fig
six
fraction
collect
top
gradient
boil
l
sampl
buffer
contain
dithiothreitol
dtt
subject
page
transfer
nitrocellulos
fraction
probe
locat
envapi
use
antibodi
n
terminu
subunit
blot
develop
ecl
result
expos
envapi
float
top
gradient
liposom
similar
result
seen
procedur
absenc
envapi
remain
bottom
gradient
fig
liposom
float
top
fraction
data
shown
eppendorf
tube
l
rcasbp
gfp
g
mix
ice
incub
min
liposom
l
ad
sampl
kept
incub
min
place
ice
sucros
step
gradient
creat
beckman
coulter
polycarbon
centrifug
tube
mm
l
sucros
overlaid
l
sucros
l
sucros
l
sampl
layer
top
gradient
sampl
centrifug
g
h
rotor
three
fraction
collect
top
gradient
fraction
contain
interfac
sucros
concentr
fraction
l
fraction
l
fraction
l
fig
sampl
boil
sampl
buffer
contain
dtt
fraction
l
fraction
l
fraction
l
fraction
load
onto
polyacrylamid
gel
subject
electrophoresi
gel
transfer
nitrocellulos
probe
polyclon
antibodi
matrix
protein
obtain
v
vogt
cornel
univers
ithaca
ny
blot
develop
ecl
result
aslva
particl
mix
liposom
incub
absenc
aslva
sediment
bottom
third
fraction
gradient
top
sucros
cushion
fig
top
contrast
aslva
preincub
incub
liposom
viru
particl
larg
retain
top
two
fraction
gradient
fig
bottom
initi
studi
employ
assay
conduct
assay
describ
proven
util
studi
receptor
tva
induc
activ
aslv
enva
also
use
studi
receptoractiv
viral
fusion
protein
one
viral
glycoprotein
one
simpl
host
cell
receptor
involv
possibl
develop
assay
directli
analog
describ
studi
tvainduc
bind
enva
ectodomain
envapi
target
membran
gener
prerequisit
fusion
proteintarget
membran
bind
assay
solubl
correctli
oligomer
form
viral
fusion
protein
ectodomain
simplest
host
cell
viral
fusion
protein
bind
target
membran
receptor
would
amen
type
analysi
type
type
ii
integr
membran
protein
ie
protein
whose
ectodomain
tether
host
cell
membran
one
end
either
n
c
termin
solubl
version
ectodomain
receptor
produc
genet
engin
proteolyt
releas
fig
imag
could
use
trigger
cognat
fusion
protein
methodolog
could
similarli
applic
multimembranespan
host
cell
receptor
function
part
receptor
tether
one
end
fig
imag
ectodomain
loop
fig
imag
preserv
enough
structur
function
solubl
analog
perhap
gener
cyclic
peptid
analog
loop
receptor
reagent
fig
could
employ
intact
viru
particletarget
membran
bind
assay
fig
singl
oblig
receptor
meet
abovecit
criteria
case
strain
hiv
may
necessari
reconstitut
one
receptor
eg
chemokin
receptor
hiv
target
liposom
hiv
solubl
ectodomain
fragment
well
target
liposom
contain
chemokin
receptor
could
use
recapitul
target
membran
bind
step
fusion
reaction
fig
step
addit
hiv
env
present
anoth
challeng
develop
membran
bind
assay
envelop
glycoprotein
possess
two
subunit
coval
associ
subunit
hiv
env
associ
way
shown
subunit
shed
bind
receptor
therefor
necessari
take
consider
make
solubl
form
glycoprotein
case
paramyxovirus
two
viral
glycoprotein
necessari
optim
fusion
actual
fusion
protein
f
cognat
hn
protein
contain
host
cell
receptor
bind
activ
system
may
possibl
induc
bind
isol
fusion
protein
ectodomain
target
liposom
even
presenc
correctli
oligomer
solubl
form
hn
protein
fusion
hn
protein
may
need
precis
configur
one
anoth
plane
membran
hn
protein
abl
activ
f
protein
type
type
ii
integr
membran
protein
function
domain
tether
membran
one
end
multimembranespan
protein
possess
function
domain
tether
membran
one
end
multimembranespan
protein
extracellular
loop
retain
engin
retain
enough
structur
serv
function
domain
cleav
transmembran
domain
arrow
indic
possibl
site
cleav
function
receptor
domain
parent
protein
altern
secret
function
domain
could
produc
genet
engin
applic
could
mimick
synthet
peptid
viral
fusion
protein
bind
target
membran
case
may
easiest
least
initi
purpos
measur
receptorinduc
bind
intact
viral
subvir
particl
target
membran
fig
would
howev
requir
solubl
form
host
cell
receptor
describ
note
addit
studi
demonstr
bind
aslva
particl
target
liposom
sever
low
phtrigger
virus
demonstr
bind
liposom
either
whole
viru
particl
subvir
particl
case
includ
sindbi
viru
tbe
influenza
tabl
summari
key
principl
underli
oper
envelop
viru
fusion
protein
convers
fusion
protein
ectodomain
hydrophil
hydrophob
entiti
virtu
expos
fusion
peptid
fig
step
mani
case
tabl
event
appear
induc
bind
host
cell
receptor
fusionpermiss
condit
eg
physiolog
temperatur
deriv
assay
describ
chapter
prove
use
monitor
critic
unifi
event
receptorinduc
fusion
receptorinduc
bind
fusion
protein
target
membran
possibl
either
free
oligomer
fusion
protein
ectodomain
intact
viral
particl
subvir
particl
contain
viral
fusion
protein
target
membran
bind
assay
establish
provid
power
tool
dissect
requir
key
step
fusion
cascad
hydrophob
bind
fusion
protein
host
cell
bilay
fig
step
